Tag: Parkinson's Disease

GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen

GlycoNet partner company, Alectos Therapeutics, enters ground-breaking $700 million agreement with Biogen

This collaboration combines Alectos’ expertise in small-molecule therapeutics with Biogen’s development capabilities in movement disorders.

en_USEnglish
Scroll to Top